Johnson & Johnson (JNJ) Total Non-Current Liabilities (2009 - 2026)

Johnson & Johnson has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $119.2 billion for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $119.2 billion, up 4.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.2 billion (up 4.28% YoY), and the FY2025 annual result was $117.2 billion, up 9.11% from the prior year.
• Total Non-Current Liabilities came in at $119.2 billion for Q1 2026 at Johnson & Johnson, up from $117.2 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $124.0 billion in Q2 2023 to a low of $93.7 billion in Q4 2023.
• The 5-year median for Total Non-Current Liabilities is $107.2 billion (2024), against an average of $107.4 billion.
• Across the five-year window, Total Non-Current Liabilities increased 20.16% in 2023 and decreased 18.66% in 2024, its largest moves.
• Johnson & Johnson's Total Non-Current Liabilities stood at $100.0 billion in 2022, then retreated by 2.31% to $97.7 billion in 2023, then grew by 9.93% to $107.4 billion in 2024, then advanced by 9.11% to $117.2 billion in 2025, then advanced by 1.74% to $119.2 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $119.2 billion (Q1 2026), $117.2 billion (Q4 2025), and $103.6 billion (Q3 2025), per Business Quant data.